Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06866522

Light Reflection on Human Skin in Whole-Body Photobiomodulation Therapy

Light Reflection on Human Skin in Whole-Body Photobiomodulation Therapy: Clinical Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
72 (estimated)
Sponsor
Universidade Federal de Sao Carlos · Academic / Other
Sex
All
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

Photobiomodulation therapy (PBMT) is based on exposing biological tissues to low-intensity light, with effects depending on the light-tissue interaction. When irradiated without skin contact, part of the incident light is reflected and lost. In this context, the amount of reflected light in PBMT applied without skin contact, as well as the influence of skin phototype, has not yet been established. Objective: To quantify the reflection of light from PBMT on the skin of men and women aged 18 to 30 years, considering skin phototypes. Methodology: Participants will be divided into three groups based on skin phototype (Group 1: phototypes I and II; Group 2: phototypes III and IV; Group 3: phototypes V and VI) and sex. They will be subjected to whole-body PBMT with red light (660 nm; 31.85±3.85 mW; 45.50±5.07 mW/cm²) and infrared light (850 nm; 25.29±2.99 mW; 36.13±4.27 mW/cm²) at 20 cm from the light-emitting source, with measurement of light reflection in the regions of the brachial biceps, abdomen, lumbar, anterior and posterior thigh, and calf using a power and energy analyzer (powermeter PM100D and sensor S130C, 0.7 cm²). Data will be analyzed for normality and groups were compared with a significance level of 5%

Conditions

Interventions

TypeNameDescription
DEVICEWhole-body Photobiomodulation TherapyWhole-body Photobiomodulation Therapy applied for approximately 10 minutes, being 5 minutes with the red wavelength and 5 minutes with the infrared wavelength.

Timeline

Start date
2023-11-27
Primary completion
2025-03-20
Completion
2025-07-20
First posted
2025-03-10
Last updated
2025-03-12

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT06866522. Inclusion in this directory is not an endorsement.